Juvenile Alpers disease

Archives of Neurology

Volumn 65, Issue 1, 2008, Pages 121-124

  Wiltshire, Esko ^a,b   Davidzon, Guido ^c   Dimauro, Salvatore ^c,e   Akman, Hasan O ^c   Sadleir, Lynette ^a   Haas, Lindsay ^b   Zuccollo, Jane ^a   McEwen, Alison ^b   Thorburn, David R ^d  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b CAPITAL AND COAST DISTRICT HEALTH BOARD   (New Zealand)

^c NewYork Presbyterian Hospital   (United States)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e 3 313 Russ Berrie Medical Science Pavilion ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; MIDAZOLAM; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VALPROIC ACID;

ADOLESCENT; ALPERS DISEASE; ARTICLE; CASE REPORT; ENZYME ANALYSIS; EPILEPTIC STATE; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; INTRACTABLE EPILEPSY; LIVER DISEASE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT DISEASE; TERTIARY HEALTH CARE; UNIVERSITY HOSPITAL;

ADOLESCENT; ANTICONVULSANTS; BRAIN; DIFFUSE CEREBRAL SCLEROSIS OF SCHILDER; DNA MUTATIONAL ANALYSIS; DNA-DIRECTED DNA POLYMERASE; DRUG RESISTANCE; ELECTROENCEPHALOGRAPHY; ELECTRON TRANSPORT; EXONS; FAMILY; FEMALE; HETEROZYGOTE; HUMANS; LIVER DISEASES; MAGNETIC RESONANCE IMAGING; MUTATION; SEIZURES;

EID: 38349076499     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2007.14     Document Type: Article

References (21)

1. Alpers BJ. Diffuse progressive degeneration of the gray matter of the cerebrum. Arch Neurol Psychiatry. 1931;25:469-505.
2. Huttenlocher PR, Solitaire GB, Adams G. Infantile diffuse cerebral degeneration with hepatic cirrhosis. Arch Neurol. 1976;33(3):186-192.
3. Harding BN. Progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher syndrome): a personal review. J Child Neurol. 1990;5(4):273-287.
4. Harding BN, Egger J, Portmann B, Erdohazi M. Progressive neuronal degeneration of childhood with liver disease: a pathological study. Brain. 1986;109:181-206.
5. Narkewicz MR, Sokol RJ, Beckwith B, et al. Liver involvement in Alpers disease. J Pediatr. 1991;119(2):260-267.
6. Naviaux RK, Nguyen KV. POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion. Ann Neurol. 2004;55(5):706-712.
7. Ferrari G, Lamantea E, Donati A, et al. Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-γA. Brain. 2005;128(pt 4):723-731.
8. Davidzon G, Mancuso M, Ferraris S, et al. POLG mutations and Alpers syndrome. Ann Neurol. 2005;57(6):921-924.
9. Horvath R, Hudson G, Ferrari G, et al. Phenotypic spectrum associated with mutations of the mitochondrial polymerase gene. Brain. 2006;129(pt 7):1674-1684.
10. Tzoulis C, Engelsen BA, Telstad W, et al. The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. Brain. 2006;129(pt 7):1685-1692.
11. Kirby DM, Crawford M, Cleary MA, et al. Respiratory chain complex I deficiency: an underdiagnosed energy generation disorder. Neurology. 1999;52(6):1255-1264.
12. Lamantea E, Tiranti V, Bordoni A, et al. Mutations of mitochondrial DNA polymerase γA are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia. Ann Neurol. 2002;52(2):211-219.
13. Agostino A, Valletta L, Chinnery PF, et al. Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive external ophthalmoplegia (PEO). Neurology. 2003;60(8):1354-1356.
14. Wörle H, Kohler B, Schlote W, et al. Progressive cerebral degeneration of childhood with liver disease (Alpers Huttenlocher disease) with cytochrome oxidase deficiency presenting with epilepsia partialis continua as the first clinical manifestation. Clin Neuropathol. 1998;17(2):63-68.
15. Harding BN, Alsanjari N, Smith SJM, et al. Progressive neuronal degeneration of childhood with liver disease (Alpers' disease) presenting in young adults. J Neurol Neurosurg Psychiatry. 1995;58(3):320-325.
16. Nguyen KV, Ostergard E, Ravn SH, et al. POLG mutations in Alpers syndrome. Neurology. 2005;65(9):1493-1495.
17. Van Goethem G, Dermaut B, Lofgren A, et al. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet. 2001;28(3):211-212.
18. Van Goethem G, Martin JJ, Dermaut B, et al. Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia. Neuromuscul Disord. 2003;13(2):133-142.
19. Van Goethem G, Luoma P, Rantamaki M, et al. POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement. Neurology. 2004;63(7):1251-1257.
20. Naviaux RK, Nyhan WL, Barshop BA, et al. Mitochondrial DNA polymerase gamma deficiency and mtDNA depletion in a child with Alpers' syndrome. Ann Neurol. 1999;45(1):54-58.
21. DiMauro S, Davidzon G, Hirano M. A polymorphic polymerase. Brain. 2006;129(pt 7):1637-1639.